Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Goossens

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Nanomedicine : Nanotechnology, Biology, and Medicine|November 22, 2017
Cell type-specific pharmacological kinase inhibition for cancer chemopreventionManjeet Deshmukh, Shigeki Nakagawa, Takaaki Higashi, et al.
Hepatology (Baltimore, Md.)|March 16, 2026
Chemoprevention of hepatocellular carcinoma by next-generation antipsychotic aripiprazoleNevena Slović, Sumit Mishra, Subhojit Paul, et al.
Hepatology (Baltimore, Md.)|December 20, 2011
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypesPierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, et al.
JAMA Network Open|March 21, 2025
Surgical Site Infections, Risk Factors, and Outcomes After Liver TransplantPeter W Schreiber, Linard D Hoessly, Katia Boggian, et al.
Gastroenterology|November 22, 2017
Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic HepatitisEric Trépo, Nicolas Goossens, Naoto Fujiwara, et al.
Hepatology (Baltimore, Md.)|March 5, 2025
Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort studyBeat Moeckli, Charles-Henri Wassmer, Sofia El Hajji, et al.
Nature Communications|November 25, 2018
Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of YapYoungmin A Lee, Luke A Noon, Kemal M Akat, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 27, 2026
Preformed donor-specific antibodies are associated with acute rejection and biliary complications after liver transplantation: A Swiss Transplant Cohort Study analysisJulien Vionnet, Sylvie Ferrari-Lacraz, Linard David Hoessly, et al.
Science Translational Medicine|June 22, 2022
Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver diseaseNaoto Fujiwara, Naoto Kubota, Emilie Crouchet, et al.
Cancer Cell|December 14, 2016
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway InhibitionShigeki Nakagawa, Lan Wei, Won Min Song, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Nanomedicine : Nanotechnology, Biology, and Medicine|November 22, 2017
Cell type-specific pharmacological kinase inhibition for cancer chemopreventionManjeet Deshmukh, Shigeki Nakagawa, Takaaki Higashi, et al.
Hepatology (Baltimore, Md.)|March 16, 2026
Chemoprevention of hepatocellular carcinoma by next-generation antipsychotic aripiprazoleNevena Slović, Sumit Mishra, Subhojit Paul, et al.
Hepatology (Baltimore, Md.)|December 20, 2011
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypesPierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, et al.
JAMA Network Open|March 21, 2025
Surgical Site Infections, Risk Factors, and Outcomes After Liver TransplantPeter W Schreiber, Linard D Hoessly, Katia Boggian, et al.
Gastroenterology|November 22, 2017
Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic HepatitisEric Trépo, Nicolas Goossens, Naoto Fujiwara, et al.
Hepatology (Baltimore, Md.)|March 5, 2025
Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort studyBeat Moeckli, Charles-Henri Wassmer, Sofia El Hajji, et al.
Nature Communications|November 25, 2018
Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of YapYoungmin A Lee, Luke A Noon, Kemal M Akat, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 27, 2026
Preformed donor-specific antibodies are associated with acute rejection and biliary complications after liver transplantation: A Swiss Transplant Cohort Study analysisJulien Vionnet, Sylvie Ferrari-Lacraz, Linard David Hoessly, et al.
Science Translational Medicine|June 22, 2022
Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver diseaseNaoto Fujiwara, Naoto Kubota, Emilie Crouchet, et al.
Cancer Cell|December 14, 2016
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway InhibitionShigeki Nakagawa, Lan Wei, Won Min Song, et al.
Pageof 11